PYC 2.11% 9.3¢ pyc therapeutics limited

Ann: PYC Corporate Presentation - February 2023, page-8

  1. 924 Posts.
    lightbulb Created with Sketch. 175
    yes - i would imagine functional rescue would occur even in low doses - thus we may achieve ‘unofficial’ (?) efficacy readouts - or anecdotal patient reported benefits as early as this year if Dr Chen’s/LEI’s RP11 patients make up the Part 1 Cohort.

    The more I read of this presentation the more I feel it should have been marked price sensitive - as there’s lots of new info here, with an improved content delivery style.

    Pending IND approval, all 3x programs open up to shifting up a gear - I like the objective they used:

    ”Establish human safety of PYC’s platform technology”

    This would headline PYC as a proven solution to the delivery challenge faced by the (RNA) therapeutics industry as a whole
    Last edited by Linsanity: 03/02/23
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
-0.002(2.11%)
Mkt cap ! $429.2M
Open High Low Value Volume
9.5¢ 9.5¢ 9.0¢ $215.1K 2.351M

Buyers (Bids)

No. Vol. Price($)
5 176375 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 74422 4
View Market Depth
Last trade - 11.26am 31/07/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.